For the IFNR1 and IFNR2 receptors (Figure 1B, C), in each cell population compared (CD4+, CD8+, and CD14+), the IFNR1 and IFNR2 receptors were increased in the CIN II and CIN III groups compared to the Control group IFNR1+ CD4+ (p = 0.0002); IFNR1+ CD8+ (p = 0.0011); IFNR1+ CD14+ (p = 0.0011); IFNR2+ CD4+ (p = 0.0003); IFNR2+CD8+(p = < 0.0001); and IFNR2+CD14+ (p = 0.0009). This evidence concerns the gene IFNAR1 and uterine cervix carcinoma in situ.